25 May 2013
Keywords: imclone, 3rd-qtr, income, rises, drugmaker, systems, recently
Article | 13 November 2006
US drugmaker ImClone systems, which recently appointed billionaire investor Carl Icahn as chairman following a bitter dispute with the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 November 2006
20 November 2006
24 May 2013
© 2013 thepharmaletter.com